Skip to content
Oncology Research Hub

Research area

Lymphoma clinical trials

Studies in lymphoma test investigational medications and cell-based approaches for Hodgkin and non-Hodgkin lymphoma. Whether you are looking for yourself or for someone in your family, Oncology Research Hub can help you find out if a study may be a fit.

Updated

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Lymphoma studies in numbers

lymphoma studies recruiting in the U.S.
731
states with a study site
50
studies that accept healthy volunteers
43

Source: ClinicalTrials.gov. Data processed .

Find lymphoma studies by state

These states have the most studies recruiting right now.

Lymphoma studies recruiting now

As of November 16, 2026, 731 lymphoma studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.

What they test

  • medications483
  • biologics such as vaccines or antibodies195
  • procedures155
  • other approaches127
  • radiation43

A study can test more than one.

Main purpose

  • treating a condition555
  • supportive care37
  • diagnosis9
  • other purposes9

Phase

  • Early Phase 112
  • Phase 1173
  • Phase 1/297
  • Phase 2225
  • Phase 2/32
  • Phase 346
  • Phase 47
  • No phase75
  • Observational94

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other504
  • industry177
  • government50

Who they enroll

  • adults (18 to 64)712
  • older adults (65 and over)622
  • children (under 18)183

43 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 731 studies.

Recently updated lymphoma studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

    • Phase 2
    • Ages 12 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT03258567 · updated
  2. Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    John Reneau
    Recruiting in
    Columbus, OH
    Registry record
    NCT04848064 · updated
  3. Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston, TX
    Registry record
    NCT05011045 · updated
  4. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Recruiting in
    Chicago, IL
    Registry record
    NCT05289687 · updated
  5. A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

    • No phase
    • Ages 1 to 25
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Atlanta, GA · Bethesda, MD · Boston, MA · and 4 more U.S. locations
    Registry record
    NCT05621291 · updated
  6. Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston, TX · San Antonio, TX
    Registry record
    NCT05676450 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in the United States on ClinicalTrials.gov.

What lymphoma studies look at

Lymphoma clinical trials look at investigational medications and cell-based approaches for Hodgkin and non-Hodgkin lymphoma. No two are alike. Because every trial is built around a single, specific question, the tasks involved for you, or for the person you are caring for, depend on which trial it is.

Everything tested in a trial is investigational. How well it works is not yet known, and neither is the full picture of its risks. The study is run to find those answers.

Who may be able to take part

Each lymphoma study sets its own requirements. Age, health history, current medications, and how a condition affects you can all be part of them. Some studies also enroll people who do not have the condition.

Working out eligibility is not something you or your family have to do alone. The study team checks it at a screening visit. Read how eligibility and screening work.

What taking part usually involves

  1. A first conversation

    First, a coordinator describes the study in general terms and answers your questions. Nothing else happens before that conversation.

  2. Informed consent

    The study team puts everything about the study on paper for you, and the known risks are spelled out there too. Whether to agree is then yours to decide.

  3. Screening

    The team uses health questions and tests to see whether the study is suitable for you. Some people who are screened do not go on to take part.

  4. Study visits

    Joining a lymphoma study means coming in for appointments the study team has planned in advance. Those appointments let the team follow your health as the study goes on. Withdrawal is always your decision. You can stop taking part at any point.

Questions about lymphoma studies

Do I need a diagnosis to join a study about lymphoma?

That varies by study. A confirmed diagnosis is required for some, while others assess you during screening. You will hear from the study team which applies to you.

Would I have to change the care I receive now?

Whether current care can continue differs from study to study. Some allow it and others do not. Do not change any care on your own. The study doctor goes over this with you, and before you decide you can discuss it with your own doctor.

Is there a cost to take part?

Participants generally pay nothing for study visits, study tests, or the study medication. Learn more about costs.

Ask about lymphoma studies

A coordinator will contact you once you share a few details, whether you are asking for yourself or for a family member. Asking a question does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call